Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy

There is an urgent need to establish blood biomarkers for Alzheimer's disease (AD). Although it has been speculated that brain-derived neurotrophic factor (BDNF) is associated with AD, whether it can be used as a blood biomarker has yet to be determined. We used serum, cerebrospinal fluid (CSF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Yukiko, Tsuji, Mayumi, Oguchi, Tatsunori, Kasuga, Kensaku, Kimura, Atsushi, Futamura, Akinori, Sugimoto, Azusa, Kasai, Hideyo, Kuroda, Takeshi, Yano, Satoshi, Hieda, Sotaro, Kiuchi, Yuji, Ikeuchi, Takeshi, Ono, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102980/
https://www.ncbi.nlm.nih.gov/pubmed/33967943
http://dx.doi.org/10.3389/fneur.2021.653267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102980/
https://www.ncbi.nlm.nih.gov/pubmed/33967943
http://dx.doi.org/10.3389/fneur.2021.653267

Ejemplares similares